The article discusses the complex regulation of p53, a tumor suppressor protein, through ubiquitination, primarily by Mdm2, but also involving other E3 ligases such as MdmX, HAUSP, ARF, COP1, and Pirh2. While Mdm2 is a major E3 ligase that ubiquitinates and degrades p53, recent studies suggest that other proteins also play significant roles in p53 regulation. Mdm2 is essential for p53 degradation under normal conditions, but its role is not absolute, as other factors can also regulate p53. The ubiquitination of p53 can be mono- or polyubiquitination, with different outcomes depending on the context. Mdm2 can also be regulated by post-translational modifications, such as acetylation, which can affect its ability to ubiquitinate p53. Additionally, deubiquitination enzymes like HAUSP can modulate p53 stability. The article also highlights the importance of p53 ubiquitination in various cellular processes, including cell cycle arrest, apoptosis, and DNA repair. The regulation of p53 by Mdm2 and other proteins is crucial for maintaining cellular homeostasis and preventing tumorigenesis. The findings suggest that while Mdm2 is a key player in p53 regulation, other factors also contribute to the complex network of p53 regulation. The article concludes that the regulation of p53 is a dynamic process involving multiple proteins and mechanisms, and that understanding these interactions is essential for developing therapeutic strategies targeting p53 in cancer.The article discusses the complex regulation of p53, a tumor suppressor protein, through ubiquitination, primarily by Mdm2, but also involving other E3 ligases such as MdmX, HAUSP, ARF, COP1, and Pirh2. While Mdm2 is a major E3 ligase that ubiquitinates and degrades p53, recent studies suggest that other proteins also play significant roles in p53 regulation. Mdm2 is essential for p53 degradation under normal conditions, but its role is not absolute, as other factors can also regulate p53. The ubiquitination of p53 can be mono- or polyubiquitination, with different outcomes depending on the context. Mdm2 can also be regulated by post-translational modifications, such as acetylation, which can affect its ability to ubiquitinate p53. Additionally, deubiquitination enzymes like HAUSP can modulate p53 stability. The article also highlights the importance of p53 ubiquitination in various cellular processes, including cell cycle arrest, apoptosis, and DNA repair. The regulation of p53 by Mdm2 and other proteins is crucial for maintaining cellular homeostasis and preventing tumorigenesis. The findings suggest that while Mdm2 is a key player in p53 regulation, other factors also contribute to the complex network of p53 regulation. The article concludes that the regulation of p53 is a dynamic process involving multiple proteins and mechanisms, and that understanding these interactions is essential for developing therapeutic strategies targeting p53 in cancer.